Index of reports
> Cases with Acute Myeloid Leukaemia (8)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Clolar (Clofarabine) where reactions include acute myeloid leukaemia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Clolar side effects in 62 year old male
Reported by a physician from United States on 2012-03-28
Patient: 62 year old male, weighing 71.0 kg (156.2 pounds)
Reactions: Multi-Organ Failure, Sepsis, Acute Myeloid Leukaemia, Septic Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clolar
Dosage: 37.2 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-01-24
Clolar
Dosage: 37.2 mg, unk
Start date: 2012-02-17
End date: 2012-02-17
Possible Clolar side effects in female
Reported by a physician from United States on 2012-01-10
Patient: female, weighing 73.6 kg (162.0 pounds)
Reactions: Acute Myeloid Leukaemia, Renal Failure Acute, Arrhythmia, Hypokalaemia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clolar
Dosage: 20 mg/m2, qd every 24 hours
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-18
Clolar
Dosage: 20 mg/m2, qd every 24 hours
Start date: 2011-11-07
End date: 2011-11-11
Other drugs received by patient: Vancomycin; Voriconazole; Avelox; Armodafinil; Acyclovir; Gentamicin; Zosyn; Zithromax
Possible Clolar side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-29
Patient: female, weighing 73.6 kg (162.0 pounds)
Reactions: Acute Myeloid Leukaemia, Hypokalaemia, Renal Failure Acute, Arrhythmia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clolar
Dosage: 20 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-18
Clolar
Dosage: 20 mg/m2, unk
Start date: 2011-11-07
End date: 2011-11-11
Other drugs received by patient: Zithromax; Gentamicin; Voriconazole; Acyclovir; Vancomycin; Zosyn; Avelox; Diflucan
Possible Clolar side effects in female
Reported by a physician from United States on 2011-12-22
Patient: female, weighing 73.6 kg (162.0 pounds)
Reactions: Acute Myeloid Leukaemia, Renal Failure Acute, Hypokalaemia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clolar
Dosage: 20 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-18
Clolar
Dosage: 20 mg/m2, unk
Start date: 2011-11-07
End date: 2011-11-11
Other drugs received by patient: Voriconazole; Zosyn; Vancomycin Hychloride; Zithromax; Avelox; Gentamicin; Zyvox
Possible Clolar side effects in female
Reported by a physician from United States on 2011-12-09
Patient: female, weighing 73.6 kg (162.0 pounds)
Reactions: Acute Myeloid Leukaemia, Hypokalaemia, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clolar
Dosage: 20 mg/m2, unk
Start date: 2011-11-07
End date: 2011-11-11
Clolar
Dosage: 20 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-18
Other drugs received by patient: Zyvox; Zithromax; Vancomycin; Zosyn; Voriconazole; Gentamicin; Avelox
Possible Clolar side effects in 36 year old female
Reported by a physician from Mexico on 2011-10-25
Patient: 36 year old female, weighing 78.0 kg (171.6 pounds)
Reactions: Acute Myeloid Leukaemia, Bone Marrow Failure
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Cytarabine
Dosage: 1 g/m2, qdx5
Indication: Acute Myeloid Leukaemia
Start date: 2011-04-12
End date: 2011-04-16
Clolar
Dosage: 40 mg/m2, qdx5
Indication: Acute Myeloid Leukaemia
Start date: 2011-04-12
End date: 2011-05-01
Other drugs received by patient: Neupogen
Possible Clolar side effects in 36 year old female
Reported by a physician from Mexico on 2011-10-20
Patient: 36 year old female, weighing 78.0 kg (171.6 pounds)
Reactions: Acute Myeloid Leukaemia, Bone Marrow Failure
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Cytarabine
Dosage: 1 g/m2, qdx5
Indication: Acute Myeloid Leukaemia
Start date: 2011-04-12
End date: 2011-04-16
Clolar
Dosage: 40 mg/m2, qdx5
Indication: Acute Myeloid Leukaemia
Start date: 2011-04-12
End date: 2011-05-01
Other drugs received by patient: Neupogen
Possible Clolar side effects in 36 year old female
Reported by a physician from Mexico on 2011-10-17
Patient: 36 year old female, weighing 78.0 kg (171.6 pounds)
Reactions: Acute Myeloid Leukaemia, Bone Marrow Failure
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Cytarabine
Dosage: 1 g/m2, qdx5
Indication: Acute Myeloid Leukaemia
Start date: 2011-04-12
End date: 2011-04-16
Clolar
Dosage: 40 mg/m2, qdx5
Indication: Acute Myeloid Leukaemia
Start date: 2011-05-01
End date: 2011-05-01
Other drugs received by patient: Neupogen
|